{"gene":"GABRB2","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2016,"finding":"The GABRB2 missense mutation p.Thr287Pro (c.859A>C) reduces trafficking of the β2 subunit to the cell membrane, prevents γ2 subunits from trafficking to the cell surface, and attenuates GABAA receptor channel function; peak current amplitude was reduced 96.4% while surface expression was reduced only 66%, indicating additional functional impairment beyond trafficking defects alone.","method":"Electrophysiology and immunostaining of mutant GABAA receptor subunits expressed in HEK293T cells","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro functional assay with multiple orthogonal readouts (electrophysiology + trafficking immunostaining) in a single rigorous study","pmids":["27789573"],"is_preprint":false},{"year":2021,"finding":"Functional analysis of four GABRB2 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents in Xenopus laevis oocytes, establishing loss of GABAergic inhibition as the underlying mechanism of GABRB2-associated neurodevelopmental disorders.","method":"Xenopus laevis oocyte electrophysiology","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted receptor function in oocyte system with multiple variants tested, moderate evidence base","pmids":["33325057"],"is_preprint":false},{"year":2021,"finding":"GABRB2 Dravet syndrome variants (p.F331S and p.Y181F) cause defects in receptor gating as the primary functional deficit, in contrast to GABRG2 variant (p.T90R) which primarily causes trafficking defects, indicating that β2 and α1 subunit variants are less tolerated and are functionally deficient even when expressed at the cell surface.","method":"Next-generation sequencing, electrophysiology, and receptor biogenesis assays in cell expression systems","journal":"Brain communications","confidence":"High","confidence_rationale":"Tier 1-2 — functional characterization with multiple variants, electrophysiology and trafficking assays, multiple orthogonal methods","pmids":["34095830"],"is_preprint":false},{"year":2024,"finding":"Electrophysiological analysis of 26 GABRB2 variants in α1β2γ2 receptors revealed that 17 resulted in gain-of-function (GOF) and 8 in loss-of-function (LOF) effects on core receptor properties such as GABA sensitivity; GOF variants were associated with severe developmental delay, movement disorders, and microcephaly, while LOF variants caused milder disease with fever-triggered seizures.","method":"Electrophysiology of α1β2γ2 GABAA receptors expressing patient variants, genotype-phenotype correlation","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 1 — systematic electrophysiological analysis of 26 variants with comprehensive genotype-phenotype correlation in 42 individuals","pmids":["38996765"],"is_preprint":false},{"year":2024,"finding":"The de novo GABRB2 missense mutation p.F224S causes poor trafficking of the β2 subunit to the cell membrane without affecting expression or distribution of co-expressed α1 and γ2 subunits, and significantly reduces peak current amplitude of the assembled GABAA receptor.","method":"Transient expression in HEK293T cells, surface trafficking assay, whole-cell patch clamp electrophysiology","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean functional characterization with two orthogonal methods (trafficking + electrophysiology) in a single study","pmids":["38964454"],"is_preprint":false},{"year":2018,"finding":"Gabrb2 knockout mice display prepulse inhibition deficits, locomotor hyperactivity, sociability impairments, memory deficits, and accelerated seizures; histological analysis revealed GABAergic parvalbumin-positive interneuron dystrophy, astrocyte dystrophy, and microglia activation in frontotemporal corticolimbic regions, along with elevated pro-inflammatory cytokines TNF-α and IL-6 and the oxidative stress marker malondialdehyde.","method":"Gabrb2 knockout mouse behavioral phenotyping, immunohistochemistry, ELISA for cytokines and oxidative stress markers","journal":"Translational psychiatry","confidence":"High","confidence_rationale":"Tier 2 — KO model with multiple defined phenotypic readouts and cellular/molecular mechanism identification using multiple orthogonal methods","pmids":["30013074"],"is_preprint":false},{"year":2022,"finding":"In Gabrb2-knockout mice, knockout of the β2 subunit increases the agonistic effect of allopregnanolone (ALLO) on GABAA receptors in cortical neuronal cells (patch-clamp), while GABA A receptor δ subunit expression is significantly elevated in the brain, suggesting the ALLO binding site is not located on the β2 subunit and that β2 deletion leads to compensatory subunit changes.","method":"Patch-clamp electrophysiology, Western blot, ELISA in Gabrb2-knockout mice","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in KO model with mechanistic interpretation, single lab","pmids":["36287173"],"is_preprint":false},{"year":2010,"finding":"GABRB2 is imprinted, as demonstrated by transmission disequilibrium tests showing significant differences between paternal and maternal transmission of the disease-associated SNP rs6556547; allelic expression flipping in heterozygotes and bisulfite sequencing-confirmed hypermethylation near rs1816071 were consistent with imprinting-based epigenetic regulation.","method":"Transmission disequilibrium test, allele-specific expression analysis, bisulfite sequencing","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple orthogonal genetic and epigenetic methods in one study, single lab","pmids":["20404824"],"is_preprint":false},{"year":2011,"finding":"GABRB2 expression is under epigenetic regulation by HDACs and DNMTs; significant co-variation of HDAC1 and HDAC2 with GABRB2 expression was observed in controls but was disrupted in schizophrenia and bipolar disorder patients.","method":"Real-time PCR of GABRB2 isoforms and epigenetic regulatory enzymes in mouse and postmortem human brains","journal":"Schizophrenia research","confidence":"Low","confidence_rationale":"Tier 3 — correlational expression analysis in postmortem brain, no direct manipulation of epigenetic enzymes","pmids":["22206711"],"is_preprint":false},{"year":2016,"finding":"GABRB2 promoter methylation (5mC) and hydroxymethylation (5hmC) regulate its transcription; demethylation by 5-azacytidine elevated GABRB2 mRNA in neuroblastoma IMR32 cells, and valproic acid-induced histone H4 acetylation of the Alu-Yi6 region also increased GABRB2 expression. The promoter with the minor allele T of rs3811997 showed enhanced promoter activity in luciferase reporter assays.","method":"Bisulfite sequencing, 5-azacytidine treatment, valproic acid treatment, luciferase reporter assay in HEK293 and IMR32 cells","journal":"Journal of psychiatric research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (pharmacological demethylation, HDAC inhibition, reporter assay) demonstrating epigenetic regulation of transcription","pmids":["28063323"],"is_preprint":false},{"year":1994,"finding":"The GABRB2 gene is located on human chromosome 5q34-q35 and forms a gene cluster with GABRA1 and GABRG2, which together encode the most abundant GABAA receptor isoform; intron position is conserved in the beta 1-3 genes, suggesting an ancestral alpha-beta-gamma cluster was duplicated to multiple chromosomes.","method":"Microdissection and chromosomal mapping","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal mapping by microdissection, foundational genomic organization study","pmids":["7851879"],"is_preprint":false},{"year":2025,"finding":"Four epilepsy-associated missense variants in GABRB2 (Q209F210delinsH, R240T, I246T, I299S) reduce GABA-induced peak chloride current in HEK293T cells and cause varying degrees of ER retention, compromised subunit assembly, decreased protein stability, and reduced trafficking and surface expression; Q209F210delinsH and R240T caused the most severe degradation, indicating misfolding and aggregation before assembly with partner subunits.","method":"Electrophysiology, ER retention assay, protein stability assay, surface expression assay in HEK293T cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 — multiple orthogonal biochemical and functional assays on four variants, single preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.03.09.642292"],"is_preprint":true},{"year":2024,"finding":"miR-144-3p directly targets GABRB2 (confirmed by dual-luciferase reporter assay) and negatively regulates its expression in thyroid cancer cells; GABRB2 knockdown reduced proliferation, invasion, and migration and increased apoptosis, while overexpression reversed these effects; miR-144-3p overexpression reduced PI3K/AKT activation, which was partially rescued by GABRB2 overexpression.","method":"Dual-luciferase reporter assay, siRNA knockdown, overexpression, CCK-8, Transwell, flow cytometry","journal":"Cell biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2-3 — dual-luciferase validation of miR-144-3p targeting plus multiple functional readouts, single lab","pmids":["39093515"],"is_preprint":false},{"year":2017,"finding":"GABRB2 knockdown in papillary thyroid carcinoma cell lines (BCPAP, TPC1, KTC-1) significantly inhibited colony formation, migration, and invasion, establishing a functional role for GABRB2 in tumor cell behavior.","method":"siRNA knockdown, colony formation assay, CCK-8, Transwell migration and invasion assays, apoptosis assay","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — KD with phenotypic readouts but no upstream/downstream pathway placement or mechanistic detail beyond loss-of-function","pmids":["28859983"],"is_preprint":false}],"current_model":"GABRB2 encodes the β2 subunit of the GABAA receptor, which assembles as a heteropentamer (typically α1β2γ2) to form a ligand-gated chloride channel mediating fast GABAergic inhibition; disease-associated missense variants cause either loss-of-function (via ER retention, impaired subunit assembly, reduced surface trafficking, and/or attenuated channel gating) or gain-of-function effects on GABA sensitivity, with GOF variants producing more severe neurodevelopmental phenotypes including dystonia and microcephaly, while LOF variants cause milder epilepsy; the gene is also subject to genomic imprinting and epigenetic regulation via promoter DNA methylation and histone deacetylation."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing the genomic context of GABRB2 — its clustering with GABRA1 and GABRG2 on chromosome 5q34-q35 — revealed that these three genes encode the subunits of the most abundant GABAA receptor isoform and arose by ancestral cluster duplication.","evidence":"Chromosomal microdissection and gene mapping","pmids":["7851879"],"confidence":"High","gaps":["No functional characterization of the receptor at this stage","Gene structure established but subunit stoichiometry not addressed"]},{"year":2010,"claim":"Discovery that GABRB2 is genomically imprinted, with parent-of-origin–dependent allelic expression and promoter methylation, introduced an epigenetic dimension to its regulation not previously appreciated for GABAA receptor genes.","evidence":"Transmission disequilibrium test, allele-specific expression, and bisulfite sequencing in human samples","pmids":["20404824"],"confidence":"Medium","gaps":["Imprinting not confirmed in independent cohorts","Functional consequence of imprinting on receptor density or neuronal inhibition unknown"]},{"year":2016,"claim":"Functional dissection of the p.Thr287Pro variant demonstrated that a single GABRB2 missense mutation causes both a trafficking defect (reduced β2 surface expression) and an additional gating impairment, establishing dual mechanisms of loss-of-function for disease-associated variants.","evidence":"Electrophysiology and immunostaining of mutant α1β2γ2 receptors in HEK293T cells","pmids":["27789573"],"confidence":"High","gaps":["Whether trafficking versus gating deficits predominate for other variants was untested","No in vivo validation of the variant's impact on inhibitory neurotransmission"]},{"year":2016,"claim":"Direct manipulation of promoter methylation and histone acetylation showed that GABRB2 transcription is positively regulated by demethylation and HDAC inhibition, providing a mechanistic basis for the epigenetic control of β2 subunit levels.","evidence":"5-azacytidine and valproic acid treatment of neuroblastoma and HEK293 cells, bisulfite sequencing, luciferase reporter assays","pmids":["28063323"],"confidence":"Medium","gaps":["Epigenetic regulation not demonstrated in primary neurons","Whether altered methylation levels occur in disease brain tissue was not tested"]},{"year":2018,"claim":"Gabrb2 knockout mice provided the first in vivo evidence that loss of the β2 subunit leads to GABAergic interneuron degeneration, neuroinflammation, seizure susceptibility, and a broad behavioral phenotype encompassing hyperactivity, social deficits, and memory impairment.","evidence":"KO mouse behavioral testing, immunohistochemistry, ELISA for cytokines and oxidative stress markers","pmids":["30013074"],"confidence":"High","gaps":["Conditional or cell-type–specific knockout not performed","Whether compensatory subunit changes (e.g., δ subunit upregulation) contribute to phenotype was unexplored at this stage"]},{"year":2021,"claim":"Systematic functional analysis of multiple transmembrane-domain variants (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) in reconstituted receptors confirmed that reduced GABA-evoked chloride current is a shared loss-of-function mechanism across GABRB2-associated neurodevelopmental disorders, while separate work on Dravet variants showed that gating defects — rather than trafficking deficits — are the primary functional deficit of certain β2 mutations.","evidence":"Oocyte two-electrode voltage-clamp electrophysiology; HEK cell electrophysiology and biogenesis assays","pmids":["33325057","34095830"],"confidence":"High","gaps":["Whether gating versus trafficking defects predict clinical severity was not yet determined","Structural basis for differential gating impairment unresolved"]},{"year":2022,"claim":"In Gabrb2-KO mice, the enhanced agonistic effect of allopregnanolone and compensatory upregulation of the δ subunit indicated that β2 loss triggers subunit remodeling that alters GABAA receptor pharmacology, establishing that the allopregnanolone binding site is not on the β2 subunit.","evidence":"Patch-clamp electrophysiology, Western blot, and ELISA in Gabrb2-KO cortical neurons","pmids":["36287173"],"confidence":"Medium","gaps":["Single-lab study; compensatory subunit changes not validated at single-cell resolution","Physiological relevance of enhanced ALLO sensitivity in vivo not assessed"]},{"year":2024,"claim":"The largest variant-function correlation to date — 26 GABRB2 variants in α1β2γ2 receptors — established that gain-of-function effects on GABA sensitivity are more common than loss-of-function and correlate with severe phenotypes (developmental delay, dystonia, microcephaly), while LOF variants produce milder fever-triggered seizures, fundamentally reframing the genotype–phenotype landscape.","evidence":"Systematic electrophysiology of 26 variants with clinical phenotyping of 42 individuals","pmids":["38996765"],"confidence":"High","gaps":["No structural explanation for why specific residue changes produce GOF versus LOF","Whether GOF variants cause tonic receptor activation in vivo is untested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of GOF versus LOF effects, whether compensatory subunit remodeling occurs in patients, and whether the epigenetic (imprinting/methylation) regulation of GABRB2 contributes to variable penetrance of disease-associated variants.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of disease variant-containing α1β2γ2 receptors","No patient-derived iPSC or neuronal model confirming variant effects","Contribution of imprinting to phenotypic variability not tested in variant carriers"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,3,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,11]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,2,3,5,6]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,3]}],"complexes":["GABAA receptor (α1β2γ2)"],"partners":["GABRA1","GABRG2","GABRD"],"other_free_text":[]},"mechanistic_narrative":"GABRB2 encodes the β2 subunit of the GABAA receptor, the principal ligand-gated chloride channel mediating fast inhibitory neurotransmission in the brain. The β2 subunit assembles with α1 and γ2 subunits into the most abundant GABAA receptor isoform (α1β2γ2), and disease-associated missense variants impair receptor function through distinct mechanisms including ER retention, defective subunit assembly, reduced surface trafficking, and altered channel gating, with gain-of-function variants producing severe neurodevelopmental phenotypes (dystonia, microcephaly) and loss-of-function variants causing milder epilepsy [PMID:27789573, PMID:33325057, PMID:38996765]. Gabrb2 knockout in mice causes GABAergic interneuron dystrophy, neuroinflammation, seizure susceptibility, and behavioral deficits encompassing locomotor hyperactivity, impaired sociability, and memory dysfunction [PMID:30013074]. GABRB2 transcription is subject to genomic imprinting and epigenetic regulation through promoter DNA methylation and histone deacetylation, with pharmacological demethylation and HDAC inhibition each elevating its expression [PMID:20404824, PMID:28063323]."},"prefetch_data":{"uniprot":{"accession":"P47870","full_name":"Gamma-aminobutyric acid receptor subunit beta-2","aliases":["GABA(A) receptor subunit beta-2","GABAAR subunit beta-2"],"length_aa":512,"mass_kda":59.1,"function":"Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:19763268, PubMed:27789573, PubMed:29950725, PubMed:8264558). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (By similarity). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). GABAARs containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (PubMed:23909897, PubMed:25489750). Extrasynaptic beta-2 receptors contribute to the tonic GABAergic inhibition (By similarity). Beta-containing GABAARs can simultaneously bind GABA and histamine where histamine binds at the interface of two neighboring beta subunits, which may be involved in the regulation of sleep and wakefulness (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane; Cytoplasmic vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P47870/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRB2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRB2","total_profiled":1310},"omim":[{"mim_id":"617829","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92; DEE92","url":"https://www.omim.org/entry/617829"},{"mim_id":"610045","title":"ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1","url":"https://www.omim.org/entry/610045"},{"mim_id":"607334","title":"TRAFFICKING PROTEIN, KINESIN-BINDING 2; TRAK2","url":"https://www.omim.org/entry/607334"},{"mim_id":"600429","title":"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME; GCNT2","url":"https://www.omim.org/entry/600429"},{"mim_id":"600233","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3","url":"https://www.omim.org/entry/600233"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":41.3}],"url":"https://www.proteinatlas.org/search/GABRB2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P47870","domains":[{"cath_id":"2.70.170.10","chopping":"34-240","consensus_level":"high","plddt":94.4985,"start":34,"end":240},{"cath_id":"1.20.58.390","chopping":"244-340","consensus_level":"high","plddt":89.6506,"start":244,"end":340}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P47870","model_url":"https://alphafold.ebi.ac.uk/files/AF-P47870-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P47870-F1-predicted_aligned_error_v6.png","plddt_mean":76.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRB2","jax_strain_url":"https://www.jax.org/strain/search?query=GABRB2"},"sequence":{"accession":"P47870","fasta_url":"https://rest.uniprot.org/uniprotkb/P47870.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P47870/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P47870"}},"corpus_meta":[{"pmid":"35718920","id":"PMC_35718920","title":"Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort study, review of literature, and genotype-phenotype correlation.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35718920","citation_count":67,"is_preprint":false},{"pmid":"25124326","id":"PMC_25124326","title":"A novel variant in GABRB2 associated with intellectual disability and epilepsy.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25124326","citation_count":63,"is_preprint":false},{"pmid":"7851879","id":"PMC_7851879","title":"Mapping of the beta 2 subunit gene (GABRB2) to microdissected human chromosome 5q34-q35 defines a gene cluster for the most abundant GABAA receptor isoform.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7851879","citation_count":53,"is_preprint":false},{"pmid":"27789573","id":"PMC_27789573","title":"A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27789573","citation_count":47,"is_preprint":false},{"pmid":"20404824","id":"PMC_20404824","title":"Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor β(2) subunit.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20404824","citation_count":44,"is_preprint":false},{"pmid":"16950232","id":"PMC_16950232","title":"GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16950232","citation_count":42,"is_preprint":false},{"pmid":"34095830","id":"PMC_34095830","title":"Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors.","date":"2021","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/34095830","citation_count":35,"is_preprint":false},{"pmid":"30013074","id":"PMC_30013074","title":"Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation.","date":"2018","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30013074","citation_count":30,"is_preprint":false},{"pmid":"34673206","id":"PMC_34673206","title":"GABRB2, a key player in neuropsychiatric disorders and beyond.","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34673206","citation_count":28,"is_preprint":false},{"pmid":"22206711","id":"PMC_22206711","title":"Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders.","date":"2011","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/22206711","citation_count":28,"is_preprint":false},{"pmid":"28063323","id":"PMC_28063323","title":"Genetic and epigenetic regulation on the transcription of GABRB2: Genotype-dependent hydroxymethylation and methylation alterations in schizophrenia.","date":"2016","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/28063323","citation_count":28,"is_preprint":false},{"pmid":"33325057","id":"PMC_33325057","title":"Characterization of the GABRB2-Associated Neurodevelopmental Disorders.","date":"2020","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33325057","citation_count":25,"is_preprint":false},{"pmid":"23638040","id":"PMC_23638040","title":"Social cognitive role of schizophrenia candidate gene GABRB2.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23638040","citation_count":25,"is_preprint":false},{"pmid":"16472798","id":"PMC_16472798","title":"Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping.","date":"2006","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16472798","citation_count":25,"is_preprint":false},{"pmid":"28859983","id":"PMC_28859983","title":"GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28859983","citation_count":25,"is_preprint":false},{"pmid":"20221451","id":"PMC_20221451","title":"A recombination hotspot in a schizophrenia-associated region of GABRB2.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20221451","citation_count":21,"is_preprint":false},{"pmid":"21420396","id":"PMC_21420396","title":"Potential role of GABAA receptor subunit; GABRA6, GABRB2 and GABRR2 gene polymorphisms in epilepsy susceptibility and pharmacotherapy in North Indian population.","date":"2011","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21420396","citation_count":20,"is_preprint":false},{"pmid":"15955415","id":"PMC_15955415","title":"Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15955415","citation_count":17,"is_preprint":false},{"pmid":"38996765","id":"PMC_38996765","title":"Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.","date":"2024","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/38996765","citation_count":15,"is_preprint":false},{"pmid":"27509263","id":"PMC_27509263","title":"DNA methylation regulates gabrb2 mRNA expression: developmental variations and disruptions in l-methionine-induced zebrafish with schizophrenia-like symptoms.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27509263","citation_count":15,"is_preprint":false},{"pmid":"32695026","id":"PMC_32695026","title":"Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder.","date":"2020","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32695026","citation_count":11,"is_preprint":false},{"pmid":"29894498","id":"PMC_29894498","title":"Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29894498","citation_count":10,"is_preprint":false},{"pmid":"26561861","id":"PMC_26561861","title":"GABRB2 Haplotype Association with Heroin Dependence in Chinese Population.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26561861","citation_count":10,"is_preprint":false},{"pmid":"32988247","id":"PMC_32988247","title":"Relationship between GABRB2 gene polymorphisms and schizophrenia susceptibility: a case-control study and in silico analyses.","date":"2020","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32988247","citation_count":9,"is_preprint":false},{"pmid":"35173461","id":"PMC_35173461","title":"GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility.","date":"2022","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35173461","citation_count":8,"is_preprint":false},{"pmid":"32759093","id":"PMC_32759093","title":"A de novo GABRB2 variant associated with myoclonic status epilepticus and rhythmic high-amplitude delta with superimposed (poly) spikes (RHADS).","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32759093","citation_count":6,"is_preprint":false},{"pmid":"30706170","id":"PMC_30706170","title":"The association of GABRB2 SNPs with cognitive function in schizophrenia.","date":"2019","source":"European archives of psychiatry and clinical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30706170","citation_count":5,"is_preprint":false},{"pmid":"36287173","id":"PMC_36287173","title":"Gabrb2 knock-out mice exhibit double-directed PMDD-like symptoms: GABAAR subunits, neurotransmitter metabolism disruption, and allopregnanolone binding.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/36287173","citation_count":4,"is_preprint":false},{"pmid":"31269553","id":"PMC_31269553","title":"[Clinical features of epilepsies associated with GABRB2 variants].","date":"2019","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/31269553","citation_count":3,"is_preprint":false},{"pmid":"39093515","id":"PMC_39093515","title":"miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro.","date":"2024","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/39093515","citation_count":2,"is_preprint":false},{"pmid":"38964454","id":"PMC_38964454","title":"The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABAAR function.","date":"2024","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38964454","citation_count":1,"is_preprint":false},{"pmid":"41174677","id":"PMC_41174677","title":"Methylation-Driven downregulation of GABRB2 in oral carcinoma's subtype: implications for early diagnosis and differentiation.","date":"2025","source":"BMC oral health","url":"https://pubmed.ncbi.nlm.nih.gov/41174677","citation_count":0,"is_preprint":false},{"pmid":"40977746","id":"PMC_40977746","title":"Genetic insights into schizophrenia: ERBB4 and GABRB2 polymorphisms in the Lebanese population.","date":"2025","source":"IBRO neuroscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/40977746","citation_count":0,"is_preprint":false},{"pmid":"41603155","id":"PMC_41603155","title":"Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.","date":"2026","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/41603155","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.09.642292","title":"Missense variants in GABA<sub>A</sub>receptor beta2 subunit disrupt receptor biogenesis and cause loss of function","date":"2025-03-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.09.642292","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.02.606341","title":"Targeting of retrovirus-derived<i>Rtl8a</i>/<i>8b</i>reduces social response and increases apathy-like behavior associated with GABRB2 reduction","date":"2024-08-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.02.606341","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21538,"output_tokens":3412,"usd":0.057897},"stage2":{"model":"claude-opus-4-6","input_tokens":6856,"output_tokens":2299,"usd":0.137632},"total_usd":0.195529,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"The GABRB2 missense mutation p.Thr287Pro (c.859A>C) reduces trafficking of the β2 subunit to the cell membrane, prevents γ2 subunits from trafficking to the cell surface, and attenuates GABAA receptor channel function; peak current amplitude was reduced 96.4% while surface expression was reduced only 66%, indicating additional functional impairment beyond trafficking defects alone.\",\n      \"method\": \"Electrophysiology and immunostaining of mutant GABAA receptor subunits expressed in HEK293T cells\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional assay with multiple orthogonal readouts (electrophysiology + trafficking immunostaining) in a single rigorous study\",\n      \"pmids\": [\"27789573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Functional analysis of four GABRB2 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents in Xenopus laevis oocytes, establishing loss of GABAergic inhibition as the underlying mechanism of GABRB2-associated neurodevelopmental disorders.\",\n      \"method\": \"Xenopus laevis oocyte electrophysiology\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted receptor function in oocyte system with multiple variants tested, moderate evidence base\",\n      \"pmids\": [\"33325057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GABRB2 Dravet syndrome variants (p.F331S and p.Y181F) cause defects in receptor gating as the primary functional deficit, in contrast to GABRG2 variant (p.T90R) which primarily causes trafficking defects, indicating that β2 and α1 subunit variants are less tolerated and are functionally deficient even when expressed at the cell surface.\",\n      \"method\": \"Next-generation sequencing, electrophysiology, and receptor biogenesis assays in cell expression systems\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional characterization with multiple variants, electrophysiology and trafficking assays, multiple orthogonal methods\",\n      \"pmids\": [\"34095830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Electrophysiological analysis of 26 GABRB2 variants in α1β2γ2 receptors revealed that 17 resulted in gain-of-function (GOF) and 8 in loss-of-function (LOF) effects on core receptor properties such as GABA sensitivity; GOF variants were associated with severe developmental delay, movement disorders, and microcephaly, while LOF variants caused milder disease with fever-triggered seizures.\",\n      \"method\": \"Electrophysiology of α1β2γ2 GABAA receptors expressing patient variants, genotype-phenotype correlation\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic electrophysiological analysis of 26 variants with comprehensive genotype-phenotype correlation in 42 individuals\",\n      \"pmids\": [\"38996765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The de novo GABRB2 missense mutation p.F224S causes poor trafficking of the β2 subunit to the cell membrane without affecting expression or distribution of co-expressed α1 and γ2 subunits, and significantly reduces peak current amplitude of the assembled GABAA receptor.\",\n      \"method\": \"Transient expression in HEK293T cells, surface trafficking assay, whole-cell patch clamp electrophysiology\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean functional characterization with two orthogonal methods (trafficking + electrophysiology) in a single study\",\n      \"pmids\": [\"38964454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gabrb2 knockout mice display prepulse inhibition deficits, locomotor hyperactivity, sociability impairments, memory deficits, and accelerated seizures; histological analysis revealed GABAergic parvalbumin-positive interneuron dystrophy, astrocyte dystrophy, and microglia activation in frontotemporal corticolimbic regions, along with elevated pro-inflammatory cytokines TNF-α and IL-6 and the oxidative stress marker malondialdehyde.\",\n      \"method\": \"Gabrb2 knockout mouse behavioral phenotyping, immunohistochemistry, ELISA for cytokines and oxidative stress markers\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO model with multiple defined phenotypic readouts and cellular/molecular mechanism identification using multiple orthogonal methods\",\n      \"pmids\": [\"30013074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In Gabrb2-knockout mice, knockout of the β2 subunit increases the agonistic effect of allopregnanolone (ALLO) on GABAA receptors in cortical neuronal cells (patch-clamp), while GABA A receptor δ subunit expression is significantly elevated in the brain, suggesting the ALLO binding site is not located on the β2 subunit and that β2 deletion leads to compensatory subunit changes.\",\n      \"method\": \"Patch-clamp electrophysiology, Western blot, ELISA in Gabrb2-knockout mice\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in KO model with mechanistic interpretation, single lab\",\n      \"pmids\": [\"36287173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GABRB2 is imprinted, as demonstrated by transmission disequilibrium tests showing significant differences between paternal and maternal transmission of the disease-associated SNP rs6556547; allelic expression flipping in heterozygotes and bisulfite sequencing-confirmed hypermethylation near rs1816071 were consistent with imprinting-based epigenetic regulation.\",\n      \"method\": \"Transmission disequilibrium test, allele-specific expression analysis, bisulfite sequencing\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple orthogonal genetic and epigenetic methods in one study, single lab\",\n      \"pmids\": [\"20404824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GABRB2 expression is under epigenetic regulation by HDACs and DNMTs; significant co-variation of HDAC1 and HDAC2 with GABRB2 expression was observed in controls but was disrupted in schizophrenia and bipolar disorder patients.\",\n      \"method\": \"Real-time PCR of GABRB2 isoforms and epigenetic regulatory enzymes in mouse and postmortem human brains\",\n      \"journal\": \"Schizophrenia research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — correlational expression analysis in postmortem brain, no direct manipulation of epigenetic enzymes\",\n      \"pmids\": [\"22206711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GABRB2 promoter methylation (5mC) and hydroxymethylation (5hmC) regulate its transcription; demethylation by 5-azacytidine elevated GABRB2 mRNA in neuroblastoma IMR32 cells, and valproic acid-induced histone H4 acetylation of the Alu-Yi6 region also increased GABRB2 expression. The promoter with the minor allele T of rs3811997 showed enhanced promoter activity in luciferase reporter assays.\",\n      \"method\": \"Bisulfite sequencing, 5-azacytidine treatment, valproic acid treatment, luciferase reporter assay in HEK293 and IMR32 cells\",\n      \"journal\": \"Journal of psychiatric research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (pharmacological demethylation, HDAC inhibition, reporter assay) demonstrating epigenetic regulation of transcription\",\n      \"pmids\": [\"28063323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The GABRB2 gene is located on human chromosome 5q34-q35 and forms a gene cluster with GABRA1 and GABRG2, which together encode the most abundant GABAA receptor isoform; intron position is conserved in the beta 1-3 genes, suggesting an ancestral alpha-beta-gamma cluster was duplicated to multiple chromosomes.\",\n      \"method\": \"Microdissection and chromosomal mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping by microdissection, foundational genomic organization study\",\n      \"pmids\": [\"7851879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Four epilepsy-associated missense variants in GABRB2 (Q209F210delinsH, R240T, I246T, I299S) reduce GABA-induced peak chloride current in HEK293T cells and cause varying degrees of ER retention, compromised subunit assembly, decreased protein stability, and reduced trafficking and surface expression; Q209F210delinsH and R240T caused the most severe degradation, indicating misfolding and aggregation before assembly with partner subunits.\",\n      \"method\": \"Electrophysiology, ER retention assay, protein stability assay, surface expression assay in HEK293T cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biochemical and functional assays on four variants, single preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.03.09.642292\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"miR-144-3p directly targets GABRB2 (confirmed by dual-luciferase reporter assay) and negatively regulates its expression in thyroid cancer cells; GABRB2 knockdown reduced proliferation, invasion, and migration and increased apoptosis, while overexpression reversed these effects; miR-144-3p overexpression reduced PI3K/AKT activation, which was partially rescued by GABRB2 overexpression.\",\n      \"method\": \"Dual-luciferase reporter assay, siRNA knockdown, overexpression, CCK-8, Transwell, flow cytometry\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — dual-luciferase validation of miR-144-3p targeting plus multiple functional readouts, single lab\",\n      \"pmids\": [\"39093515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GABRB2 knockdown in papillary thyroid carcinoma cell lines (BCPAP, TPC1, KTC-1) significantly inhibited colony formation, migration, and invasion, establishing a functional role for GABRB2 in tumor cell behavior.\",\n      \"method\": \"siRNA knockdown, colony formation assay, CCK-8, Transwell migration and invasion assays, apoptosis assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — KD with phenotypic readouts but no upstream/downstream pathway placement or mechanistic detail beyond loss-of-function\",\n      \"pmids\": [\"28859983\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRB2 encodes the β2 subunit of the GABAA receptor, which assembles as a heteropentamer (typically α1β2γ2) to form a ligand-gated chloride channel mediating fast GABAergic inhibition; disease-associated missense variants cause either loss-of-function (via ER retention, impaired subunit assembly, reduced surface trafficking, and/or attenuated channel gating) or gain-of-function effects on GABA sensitivity, with GOF variants producing more severe neurodevelopmental phenotypes including dystonia and microcephaly, while LOF variants cause milder epilepsy; the gene is also subject to genomic imprinting and epigenetic regulation via promoter DNA methylation and histone deacetylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRB2 encodes the β2 subunit of the GABAA receptor, the principal ligand-gated chloride channel mediating fast inhibitory neurotransmission in the brain. The β2 subunit assembles with α1 and γ2 subunits into the most abundant GABAA receptor isoform (α1β2γ2), and disease-associated missense variants impair receptor function through distinct mechanisms including ER retention, defective subunit assembly, reduced surface trafficking, and altered channel gating, with gain-of-function variants producing severe neurodevelopmental phenotypes (dystonia, microcephaly) and loss-of-function variants causing milder epilepsy [PMID:27789573, PMID:33325057, PMID:38996765]. Gabrb2 knockout in mice causes GABAergic interneuron dystrophy, neuroinflammation, seizure susceptibility, and behavioral deficits encompassing locomotor hyperactivity, impaired sociability, and memory dysfunction [PMID:30013074]. GABRB2 transcription is subject to genomic imprinting and epigenetic regulation through promoter DNA methylation and histone deacetylation, with pharmacological demethylation and HDAC inhibition each elevating its expression [PMID:20404824, PMID:28063323].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the genomic context of GABRB2 — its clustering with GABRA1 and GABRG2 on chromosome 5q34-q35 — revealed that these three genes encode the subunits of the most abundant GABAA receptor isoform and arose by ancestral cluster duplication.\",\n      \"evidence\": \"Chromosomal microdissection and gene mapping\",\n      \"pmids\": [\"7851879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional characterization of the receptor at this stage\", \"Gene structure established but subunit stoichiometry not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that GABRB2 is genomically imprinted, with parent-of-origin–dependent allelic expression and promoter methylation, introduced an epigenetic dimension to its regulation not previously appreciated for GABAA receptor genes.\",\n      \"evidence\": \"Transmission disequilibrium test, allele-specific expression, and bisulfite sequencing in human samples\",\n      \"pmids\": [\"20404824\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Imprinting not confirmed in independent cohorts\", \"Functional consequence of imprinting on receptor density or neuronal inhibition unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Functional dissection of the p.Thr287Pro variant demonstrated that a single GABRB2 missense mutation causes both a trafficking defect (reduced β2 surface expression) and an additional gating impairment, establishing dual mechanisms of loss-of-function for disease-associated variants.\",\n      \"evidence\": \"Electrophysiology and immunostaining of mutant α1β2γ2 receptors in HEK293T cells\",\n      \"pmids\": [\"27789573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether trafficking versus gating deficits predominate for other variants was untested\", \"No in vivo validation of the variant's impact on inhibitory neurotransmission\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Direct manipulation of promoter methylation and histone acetylation showed that GABRB2 transcription is positively regulated by demethylation and HDAC inhibition, providing a mechanistic basis for the epigenetic control of β2 subunit levels.\",\n      \"evidence\": \"5-azacytidine and valproic acid treatment of neuroblastoma and HEK293 cells, bisulfite sequencing, luciferase reporter assays\",\n      \"pmids\": [\"28063323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Epigenetic regulation not demonstrated in primary neurons\", \"Whether altered methylation levels occur in disease brain tissue was not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Gabrb2 knockout mice provided the first in vivo evidence that loss of the β2 subunit leads to GABAergic interneuron degeneration, neuroinflammation, seizure susceptibility, and a broad behavioral phenotype encompassing hyperactivity, social deficits, and memory impairment.\",\n      \"evidence\": \"KO mouse behavioral testing, immunohistochemistry, ELISA for cytokines and oxidative stress markers\",\n      \"pmids\": [\"30013074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conditional or cell-type–specific knockout not performed\", \"Whether compensatory subunit changes (e.g., δ subunit upregulation) contribute to phenotype was unexplored at this stage\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Systematic functional analysis of multiple transmembrane-domain variants (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) in reconstituted receptors confirmed that reduced GABA-evoked chloride current is a shared loss-of-function mechanism across GABRB2-associated neurodevelopmental disorders, while separate work on Dravet variants showed that gating defects — rather than trafficking deficits — are the primary functional deficit of certain β2 mutations.\",\n      \"evidence\": \"Oocyte two-electrode voltage-clamp electrophysiology; HEK cell electrophysiology and biogenesis assays\",\n      \"pmids\": [\"33325057\", \"34095830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gating versus trafficking defects predict clinical severity was not yet determined\", \"Structural basis for differential gating impairment unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"In Gabrb2-KO mice, the enhanced agonistic effect of allopregnanolone and compensatory upregulation of the δ subunit indicated that β2 loss triggers subunit remodeling that alters GABAA receptor pharmacology, establishing that the allopregnanolone binding site is not on the β2 subunit.\",\n      \"evidence\": \"Patch-clamp electrophysiology, Western blot, and ELISA in Gabrb2-KO cortical neurons\",\n      \"pmids\": [\"36287173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study; compensatory subunit changes not validated at single-cell resolution\", \"Physiological relevance of enhanced ALLO sensitivity in vivo not assessed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The largest variant-function correlation to date — 26 GABRB2 variants in α1β2γ2 receptors — established that gain-of-function effects on GABA sensitivity are more common than loss-of-function and correlate with severe phenotypes (developmental delay, dystonia, microcephaly), while LOF variants produce milder fever-triggered seizures, fundamentally reframing the genotype–phenotype landscape.\",\n      \"evidence\": \"Systematic electrophysiology of 26 variants with clinical phenotyping of 42 individuals\",\n      \"pmids\": [\"38996765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural explanation for why specific residue changes produce GOF versus LOF\", \"Whether GOF variants cause tonic receptor activation in vivo is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of GOF versus LOF effects, whether compensatory subunit remodeling occurs in patients, and whether the epigenetic (imprinting/methylation) regulation of GABRB2 contributes to variable penetrance of disease-associated variants.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of disease variant-containing α1β2γ2 receptors\", \"No patient-derived iPSC or neuronal model confirming variant effects\", \"Contribution of imprinting to phenotypic variability not tested in variant carriers\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"complexes\": [\n      \"GABAA receptor (α1β2γ2)\"\n    ],\n    \"partners\": [\n      \"GABRA1\",\n      \"GABRG2\",\n      \"GABRD\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}